ImmunoGen, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2021 to Q3 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: ImmunoGen, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q3 2023.
ImmunoGen, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was 0.1 USD/shares.
ImmunoGen, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -0.31 USD/shares, a 62.7% increase year-over-year.
ImmunoGen, Inc. annual Earnings Per Share, Basic for 2022 was -0.88 USD/shares, a 29.4% decline from 2021.
ImmunoGen, Inc. annual Earnings Per Share, Basic for 2021 was -0.68 USD/shares, a 172% decline from 2020.
ImmunoGen, Inc. annual Earnings Per Share, Basic for 2020 was -0.25 USD/shares, a 64.3% increase from 2019.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2023	$0	$0.10	+$0.41		Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-02
Q2 2023	-$1	$0	+$0.22	+91.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-07-31
Q1 2023	-$1	$0	$0	-60%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-04-28
Q4 2022	-$1	$0	$0	-27.8%	Oct 1, 2022	Dec 31, 2022	10-K	2023-03-01
Q3 2022	-$1	$0	$0	-72.2%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	-$1	$0	$0	-60%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-07-31
Q1 2022	-$1	$0	+$0.07	+41.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-04-28
Q4 2021	-$1	$0			Oct 1, 2021	Dec 31, 2021	10-K	2023-03-01
Q3 2021		$0			Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-04
Q2 2021		$0			Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-01
Q1 2021		$0			Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-06

* An asterisk sign (*) next to the value indicates that the value is likely invalid.